Access cutting-edge anal hsil treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access anal hsil specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related anal hsil treatment provided free
This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
Sponsor: Frantz Viral Therapeutics, LLC
Check if you qualify for this anal hsil clinical trial in Chicago, IL
If you're searching for anal hsil treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anal hsil specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.